[Page H1688]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]





 RECOGNIZING DAVID SPARKS FOR CONTRIBUTIONS TO PHARMACEUTICAL INDUSTRY

  (Mr. Carter of Georgia was recognized to address the House for 5 
minutes.)
  Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize David 
Sparks for his outstanding contributions and visionary leadership in 
the pharmaceutical industry.
  As the previous CEO and current chairman of the board at the 
Professional Compounding Centers of America, PCCA, Mr. Sparks has been 
instrumental in advancing the pharmaceutical industry. Since joining 
PCCA in 1992, he has fought to protect pharmacists' rights to compound, 
playing a key role in FDA reform legislation. Before PCCA, he owned 
pharmacies in Tulsa for over two decades, pioneering the introduction 
of compounding pharmacies in hospice care.
  Committed to education, Mr. Sparks is a proud contributor to the 
SWOSU general scholarship fund, ensuring that future pharmacists have 
the essential resources to succeed. He is also an adjunct professor at 
the University of Houston College of Pharmacy and an active member of 
its Mading Society of benefactors. He remains a dedicated advocate for 
the advancement of pharmacy, continuously supporting the profession 
through leadership and philanthropy.
  Mr. Sparks' impact on the pharmaceutical industry is profound and 
lasting, and his leadership will continue to shape its future.


   Recognizing Jim Smith for Leadership in Pharmaceutical Compounding

  Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize Jim 
Smith, a distinguished leader whose dedication and vision have 
profoundly impacted both the Professional Compounding Centers of 
America, PCCA, and the healthcare industry.
  His educational background, including a bachelor of science in 
chemistry and biology from West Texas A&M University and an MBA from 
the University of Portland, has shaped his strategic leadership.
  Since joining PCCA in 2000, Mr. Smith has played a crucial role in 
the organization's growth, serving as president, chief operating 
officer, vice president of sales and marketing, and a key member of the 
strategic management team. His leadership has strengthened PCCA's core 
capabilities, driving innovation and excellence in pharmaceutical 
compounding.
  Prior to his tenure, Mr. Smith leveraged his expertise in home 
health, specialty medicine, respiratory pharmacy, long-term care 
pharmacy, and compounding support, demonstrating his commitment to 
advancing patient care.
  Today, as executive adviser to the PCCA board of directors, Mr. Smith 
continues to shape the industry, ensuring that innovation and patient 
care remain at the forefront.
  Mr. Smith's dedication exemplifies the highest standards of 
leadership and service.


 Congratulating Gus Bassani, a Visionary in Pharmaceutical Compounding

  Mr. CARTER of Georgia. Mr. Speaker, I rise today to congratulate Gus 
Bassani, a longtime leader and visionary in the pharmacy compounding 
industry who has recently assumed the role of chief executive officer 
of the Professional Compounding Centers of America, PCCA.
  Mr. Bassani earned his doctor of pharmacy degree from Drake 
University's College of Pharmacy and Health Sciences. Since then, he 
has been invaluable in various settings within the pharmaceutical 
industry.
  Mr. Bassani embraces opportunities to give back, teaching 
extemporaneous compounding principles to pharmacy students at Drake 
University.
  Mr. Bassani has been with PCCA since September 2002, actively 
participating in legislative, regulatory, and public affairs 
initiatives. At PCCA, he has been a visionary, contributing extensively 
to the organization's scientific, technical, and strategic pursuits.

  In addition to his outstanding work with PCCA, Mr. Bassani has 
previously served on the United States Pharmacopeia Compounding Expert 
Committee.
  Mr. Speaker, I congratulate Mr. Bassani on this exciting achievement, 
and I wish him the best in his new role.

                          ____________________